162 related articles for article (PubMed ID: 30823903)
1. The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
Hummel S; Kohlmann W; Kollmeyer TM; Jenkins R; Sonnen J; Palmer CA; Colman H; Abbott D; Cannon-Albright L; Cohen AL
BMC Cancer; 2019 Mar; 19(1):190. PubMed ID: 30823903
[TBL] [Abstract][Full Text] [Related]
2. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology.
Rice T; Zheng S; Decker PA; Walsh KM; Bracci P; Xiao Y; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Hsuang G; Wiemels JL; Tihan T; Pico AR; Prados MD; Chang SM; Berger MS; Caron A; Fink S; Kollmeyer T; Rynearson A; Voss J; Kosel ML; Fridley BL; Lachance DH; Eckel-Passow JE; Sicotte H; O'Neill BP; Giannini C; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 May; 15(5):535-41. PubMed ID: 23361564
[TBL] [Abstract][Full Text] [Related]
3. A noncoding single-nucleotide polymorphism at 8q24 drives
Yanchus C; Drucker KL; Kollmeyer TM; Tsai R; Winick-Ng W; Liang M; Malik A; Pawling J; De Lorenzo SB; Ali A; Decker PA; Kosel ML; Panda A; Al-Zahrani KN; Jiang L; Browning JWL; Lowden C; Geuenich M; Hernandez JJ; Gosio JT; Ahmed M; Loganathan SK; Berman J; Trcka D; Michealraj KA; Fortin J; Carson B; Hollingsworth EW; Jacinto S; Mazrooei P; Zhou L; Elia A; Lupien M; He HH; Murphy DJ; Wang L; Abyzov A; Dennis JW; Maass PG; Campbell K; Wilson MD; Lachance DH; Wrensch M; Wiencke J; Mak T; Pennacchio LA; Dickel DE; Visel A; Wrana J; Taylor MD; Zadeh G; Dirks P; Eckel-Passow JE; Attisano L; Pombo A; Ida CM; Kvon EZ; Jenkins RB; Schramek D
Science; 2022 Oct; 378(6615):68-78. PubMed ID: 36201590
[TBL] [Abstract][Full Text] [Related]
4. Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report.
Takami H; Mukasa A; Takayanagi S; Koike T; Matsuura R; Ikemura M; Ushiku T; Yoshikawa G; Shibahara J; Tanaka S; Saito N
Brain Tumor Pathol; 2023 Jan; 40(1):26-34. PubMed ID: 36572828
[TBL] [Abstract][Full Text] [Related]
5. Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.
Habiba U; Sugino H; Yordanova R; Ise K; Tanei ZI; Ishida Y; Tanikawa S; Terasaka S; Sato KI; Kamoshima Y; Katoh M; Nagane M; Shibahara J; Tsuda M; Tanaka S
Acta Neuropathol Commun; 2021 May; 9(1):95. PubMed ID: 34020723
[TBL] [Abstract][Full Text] [Related]
6. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation.
Oktay Y; Ülgen E; Can Ö; Akyerli CB; Yüksel Ş; Erdemgil Y; Durası IM; Henegariu OI; Nanni EP; Selevsek N; Grossmann J; Erson-Omay EZ; Bai H; Gupta M; Lee W; Turcan Ş; Özpınar A; Huse JT; Sav MA; Flanagan A; Günel M; Sezerman OU; Yakıcıer MC; Pamir MN; Özduman K
Sci Rep; 2016 Jun; 6():27569. PubMed ID: 27282637
[TBL] [Abstract][Full Text] [Related]
7. Co-prevalence of other tumors in patients harboring pituitary tumors.
Couldwell WT; Cannon-Albright LA
J Neurosurg; 2014 Dec; 121(6):1474-7. PubMed ID: 25259568
[TBL] [Abstract][Full Text] [Related]
8. Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.
Yip S; Butterfield YS; Morozova O; Chittaranjan S; Blough MD; An J; Birol I; Chesnelong C; Chiu R; Chuah E; Corbett R; Docking R; Firme M; Hirst M; Jackman S; Karsan A; Li H; Louis DN; Maslova A; Moore R; Moradian A; Mungall KL; Perizzolo M; Qian J; Roldan G; Smith EE; Tamura-Wells J; Thiessen N; Varhol R; Weiss S; Wu W; Young S; Zhao Y; Mungall AJ; Jones SJ; Morin GB; Chan JA; Cairncross JG; Marra MA
J Pathol; 2012 Jan; 226(1):7-16. PubMed ID: 22072542
[TBL] [Abstract][Full Text] [Related]
9. HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.
Felix M; Friedel D; Jayavelu AK; Filipski K; Reinhardt A; Warnken U; Stichel D; Schrimpf D; Korshunov A; Wang Y; Kessler T; Etminan N; Unterberg A; Herold-Mende C; Heikaus L; Sahm F; Wick W; Harter PN; von Deimling A; Reuss DE
Neuro Oncol; 2022 Dec; 24(12):2121-2132. PubMed ID: 35511748
[TBL] [Abstract][Full Text] [Related]
10. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.
Jenkins RB; Xiao Y; Sicotte H; Decker PA; Kollmeyer TM; Hansen HM; Kosel ML; Zheng S; Walsh KM; Rice T; Bracci P; McCoy LS; Smirnov I; Patoka JS; Hsuang G; Wiemels JL; Tihan T; Pico AR; Prados MD; Chang SM; Berger MS; Caron AA; Fink SR; Halder C; Rynearson AL; Fridley BL; Buckner JC; O'Neill BP; Giannini C; Lachance DH; Wiencke JK; Eckel-Passow JE; Wrensch MR
Nat Genet; 2012 Oct; 44(10):1122-5. PubMed ID: 22922872
[TBL] [Abstract][Full Text] [Related]
11. Genetic landscape of extreme responders with anaplastic oligodendroglioma.
Holdhoff M; Cairncross GJ; Kollmeyer TM; Zhang M; Zhang P; Mehta MP; Werner-Wasik M; Souhami L; Bahary JP; Kwok Y; Hartford AC; Chakravarti A; Yegnasubramanian S; Vogelstein B; Papadopoulos N; Kinzler K; Jenkins RB; Bettegowda C
Oncotarget; 2017 May; 8(22):35523-35531. PubMed ID: 28388591
[TBL] [Abstract][Full Text] [Related]
12. MR textural analysis on T
Rui W; Ren Y; Wang Y; Gao X; Xu X; Yao Z
J Magn Reson Imaging; 2018 Jul; 48(1):74-83. PubMed ID: 29140606
[TBL] [Abstract][Full Text] [Related]
13. A review of adult-type diffuse gliomas in the WHO CNS5 classification with special reference to Astrocytoma, IDH-mutant and Oligodendroglioma, IDH-mutant and 1p/19q codeleted.
Santosh V; Rao S
Indian J Pathol Microbiol; 2022 May; 65(Supplement):S14-S23. PubMed ID: 35562130
[TBL] [Abstract][Full Text] [Related]
14. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
15. IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.
Ammendola S; Broggi G; Barresi V
Histol Histopathol; 2023 Jul; 38(7):739-753. PubMed ID: 36651583
[TBL] [Abstract][Full Text] [Related]
16. Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.
Pallavajjala A; Haley L; Stinnett V; Adams E; Pallavajjala R; Huang J; Morsberger L; Hardy M; Long P; Gocke CD; Eshleman JR; Rodriguez FJ; Zou YS
Hum Pathol; 2022 Aug; 126():63-76. PubMed ID: 35561840
[TBL] [Abstract][Full Text] [Related]
17. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
18. Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results.
Ballester LY; Huse JT; Tang G; Fuller GN
Hum Pathol; 2017 Nov; 69():15-22. PubMed ID: 28549927
[TBL] [Abstract][Full Text] [Related]
19. Supratentorial multifocal gliomas associated with Ollier disease harboring IDH1 R132H mutation: A case report.
Ikeda H; Yamaguchi S; Ishi Y; Wakabayashi K; Shimizu A; Kanno-Okada H; Endo T; Ota M; Okamoto M; Motegi H; Iwasaki N; Fujimura M
Neuropathology; 2023 Oct; 43(5):413-420. PubMed ID: 36942363
[TBL] [Abstract][Full Text] [Related]
20. IDH-Mutant Astrocytoma With Chromosome 19q13 Deletion Manifesting as an Oligodendroglioma-Like Morphology.
Miyake Y; Fujii K; Nakamaura T; Ikegaya N; Matsushita Y; Gobayashi Y; Iwashita H; Udaka N; Kumagai J; Murata H; Takemoto Y; Yamanaka S; Ichimura K; Tateishi K; Yamamoto T
J Neuropathol Exp Neurol; 2021 Feb; 80(3):247-253. PubMed ID: 33432322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
